Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Registry Trial to Evaluate Utilization Frequency and Feasibility of Targeted Axillary Dissection (TAD) After Needle Biopsy and Clip Placement in Early Breast Cancer With Clinically Affected Lymph Nodes

NCT03102307 is registered in ClinicalTrials.gov with Kliniken Essen-Mitte as lead sponsor.

NCT NCT03102307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03102307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Registry Trial to Evaluate Utilization Frequency and Feasibility of Targeted Axillary Dissection (TAD) After Needle Biopsy and Clip Placement in Early Breast Cancer With Clinically Affected Lymph Nodes
Lead sponsor
Kliniken Essen-Mitte
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
October 1, 2019
Enrollment
548 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

early stage breast cancer